Herpes Advocates: Nicole’s Story

Hi, my name is Nicole and I have always thought of myself as a good person. However, sometimes, life can throw you into a dark corner that you never even dreamed imaginable. My experience with HSV2 has been devastating. I am ashamed that I allowed this to happen to me and I turned around and infectedContinue reading “Herpes Advocates: Nicole’s Story”

Request a Patient Listening Session at the FDA

Hi there Herpes Advocates, we’re happy you’re here. Advocacy Alert: Request a Patient Listening Session at the FDA The landscape for prevention of HSV in America is inadequate. There is a critical loophole without an accurate test to diagnose asymptomatic infection. Currently available FDA-approved tests for HSV are inaccurate 50% of the time with confirmatoryContinue reading “Request a Patient Listening Session at the FDA”

After Covid-19 success, patients with the world’s ‘most stigmatized’ infection push for their own Operation Warp Speed

“There has not been any kind of herpes advocacy in the 30 years that I’ve been involved in STI prevention and research. It was something that was just never addressed,” said Jeff Klausner, an infectious disease physician at UCLA and the former director of STD prevention and control at San Francisco’s public health department. “There’sContinue reading “After Covid-19 success, patients with the world’s ‘most stigmatized’ infection push for their own Operation Warp Speed”

FY 2022 Budget Includes National Strategy and Strategic Plan for HSV

Herpes Cure Advocacy is pleased to report that with the passing of FY 2022 budget that the Dept. of Health and Human Services National Strategy and Strategic Plan for the treatment and prevention of Herpes Simplex Virus has a budget of $250,000. This small investment in strategic planning is an important step forward in theContinue reading “FY 2022 Budget Includes National Strategy and Strategic Plan for HSV”

Herpes Scientists Give Impacted Communities a Voice

The University of Washington Virology Division and the Vaccine and Infectious Disease Division at Fred Hutch Cancer Center have announced a new initiative for members of the communities affected by herpes simplex virus infection to join a new Community Advisory Board that will potentially inform future scientific research and/or clinical trials. Led by renowned herpesContinue reading “Herpes Scientists Give Impacted Communities a Voice”

IgM test removal at QUEST Diagnostics is a win for Herpes clinical care

Herpes Cure Advocacy celebrates and thanks Quest Diagnostics for removing the HSV 1/2 IgM test from their product offerings. Quest Diagnostic joins Mayo Clinic in the removal of this test from their product offerings. This is a win for herpes advocacy and a small step forward to better clinical care for Herpes Simplex Virus inContinue reading “IgM test removal at QUEST Diagnostics is a win for Herpes clinical care”

Herpes Cure Pipeline 2.0

Pipeline for a Herpes Cure Herpes Cure Advocacy announces and celebrates the launch of the highly anticipated Herpes Cure Pipeline 2.0. We track the timelines for preclinical and clinical study, formulation updates, and go-to market strategies with research teams globally. The pipeline only includes teams with published data, and those with expressed interest of bringingContinue reading “Herpes Cure Pipeline 2.0”

Advocacy Preparations for FY 2023

The Herpes Cure Advocacy team is getting ready for another busy appropriations season and we need your help. Appropriations is the government process of creating a budget and deciding how public funds are spent. Every year – advocates of all kinds hold “appropriations request” meetings to ask for funds. We have a goal of meetingContinue reading “Advocacy Preparations for FY 2023”

Moderna Adds Herpes Vaccine Candidate to Pipeline

Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines.  They are best known for recent success with their mRNA-based COVID-19 vaccine. From Moderna website: Moderna’s herpes simplex virus (HSV) vaccine candidate (mRNA-1608) is aContinue reading “Moderna Adds Herpes Vaccine Candidate to Pipeline”